Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer
Clinical trial NCT02270372 · COMPLETED
Trial details
- NCT number
- NCT02270372
- Sponsor
- Cascadian Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-06-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.